anti-NAPSA antibody product blog
Tags: Antibody; Monoclonal Antibody; NAPSA; anti-NAPSA antibody;
The NAPSA napsa (Catalog #MBS476426) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Anti-NAPSA Mouse mAb reacts with Human, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s NAPSA can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC). Researchers should empirically determine the suitability of the NAPSA napsa for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The NAPSA napsa product has the following accession number(s) (GI #4758754) (NCBI Accession #NP_004842.1) (Uniprot Accession #O96009). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Anti-NAPSA Mouse mAb with the following immunoassay(s):
Western Blot (WB) (Western blot analysis using NAPSA mAb against human NAPSA recombinant protein. (Expected MW is 40.9 kDa))
Western Blot (WB) (Western blot analysis using NAPSA mAb against HEK293 (1) and NAPSA (AA)
Western Blot (WB) (Western blot analysis using NAPSA mouse mAb against rat liver tissue lysate.)
Immunohistochemistry (IHC) (Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using NAPSA mouse mAb with DAB staining.)
Immunohistochemistry (IHC) (Immunohistochemical analysis of paraffin-embedded liver cancer tissues using NAPSA mouse mAb with DAB staining.)
Entrez Summary: The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
Immunogen: Purified recombinant fragment of human NAPSA (AA: 20-158) expressed in E Coli. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing NAPSA are readily searchable from our website. Different antibodies against the same target such as NAPSA may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Kidney, Lung, Prostate, Spleen, Trachea, Uterus tissues are correlated with this protein. The following patways have been known to be associated with this gene. Carcinoma, Hepatocellular, Cardiovascular Diseases, Disease Models, Animal, Fibrosis, Hyperplasia, Kidney Diseases, Liver Diseases, Liver Neoplasms, Neoplasms, Experimental, Skin Neoplasms are some of the diseases may be linked to Anti-NAPSA Mouse mAb.